Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001213900-24-097737
Filing Date
2024-11-14
Accepted
2024-11-14 06:37:00
Documents
89

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0220567-s1_orukatherap.htm   iXBRL S-1 2374163
2 OPINION OF GIBSON, DUNN & CRUTCHER LLP ea022056701ex5-1_oruka.htm EX-5.1 8528
3 CONSENT OF PRICEWATERHOUSECOOPERS LLP ea022056701ex23-1_oruka.htm EX-23.1 1932
4 FILING FEE TABLE ea022056701ex-fee_oruka.htm EX-FILING FEES 60880
5 GRAPHIC image_001.jpg GRAPHIC 19403
6 GRAPHIC image_002.jpg GRAPHIC 373211
7 GRAPHIC image_003.jpg GRAPHIC 494200
8 GRAPHIC image_004.jpg GRAPHIC 287345
9 GRAPHIC image_005.jpg GRAPHIC 207106
10 GRAPHIC image_006.jpg GRAPHIC 518753
11 GRAPHIC image_007.jpg GRAPHIC 532091
12 GRAPHIC image_008.jpg GRAPHIC 373835
13 GRAPHIC ex5-1_001.jpg GRAPHIC 2675
  Complete submission text file 0001213900-24-097737.txt   15137904

Data Files

Seq Description Document Type Size
14 XBRL SCHEMA FILE orka-20240930.xsd EX-101.SCH 72301
15 XBRL CALCULATION FILE orka-20240930_cal.xml EX-101.CAL 33678
16 XBRL DEFINITION FILE orka-20240930_def.xml EX-101.DEF 368321
17 XBRL LABEL FILE orka-20240930_lab.xml EX-101.LAB 602047
18 XBRL PRESENTATION FILE orka-20240930_pre.xml EX-101.PRE 379028
91 EXTRACTED XBRL INSTANCE DOCUMENT ea0220567-s1_orukatherap_htm.xml XML 782652
Mailing Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025
Business Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025 650-606-7910
Oruka Therapeutics, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-283212 | Film No.: 241456990
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)